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Abstract
Background
Few cross-sectional studies report iron deficiency (ID) prevalence in women of different
race/ethnicity and ages in US or Canada.
Materials and methods
We evaluated screening observations on women who participated between 2001–2003 in a
cross-sectional, primary care-based sample of adults ages�25 y whose observations were
complete: race/ethnicity; age; transferrin saturation; serum ferritin; and HFE p.C282Y and p.
H63D alleles. We defined ID using a stringent criterion: combined transferrin saturation
<10% and serum ferritin <33.7 pmol/L (<15 μg/L). We compared ID prevalence in women of
different race/ethnicity subgrouped by age and determined associations of p.C282Y and p.
H63D to ID overall, and to ID in women ages 25–44 y with or without self-reported
pregnancy.
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Results
These 62,685 women included 27,079 whites, 17,272 blacks, 8,566 Hispanics, 7,615
Asians, 449 Pacific Islanders, 441 Native Americans, and 1,263 participants of other race/
ethnicity. Proportions of women with ID were higher in Hispanics and blacks than whites and
Asians. Prevalence of ID was significantly greater in women ages 25–54 y of all race/ethnic-
ity groups than women ages�55 y of corresponding race/ethnicity. In women ages�55 y,
ID prevalence did not differ significantly across race/ethnicity. p.C282Y and p.H63D preva-
lence did not differ significantly in women with or without ID, regardless of race/ethnicity,
age subgroup, or pregnancy.
Conclusions
ID prevalence was greater in Hispanic and black than white and Asian women ages 25–54
y. p.C282Y and p.H63D prevalence did not differ significantly in women with or without ID,
regardless of race/ethnicity, age subgroup, or pregnancy.
Introduction
Iron deficiency (ID) in women is a cosmopolitan health and nutritional problem [1]. ID in
women is associated with fatigue, impaired muscular performance, decreased ability to main-
tain body temperature on exposure to cold, mucosal and epithelial abnormalities, pica, distur-
bances in menstruation [2], adverse pregnancy outcomes [3, 4], and decreased mental
development of children [5]. The estimated prevalence of ID is lower in women in North
America than Africa, Asia, Europe, Latin America and the Caribbean, and Oceania [6], but
few cross-sectional studies report the prevalence of ID in women of different race/ethnicity
and age who reside in North America [7, 8].
Hemochromatosis is a group of heritable disorders characterized by increased iron absorp-
tion, elevated body iron stores, and increased risk for cirrhosis, diabetes, hypogonadism,
arthropathy, and bacterial infection [9, 10]. The hemochromatosis gene HFE ("high-iron") is
linked to the major histocompatibility complex on chromosome 6p [11]. HFE encodes the
major histocompatibility complex class I-like protein HFE that binds beta-2 microglobulin
[12]. HFE protein influences iron absorption by modulating the expression of hepcidin, the
main controller of iron metabolism [13]. There are two common missense mutations of HFE:
p.C282Y (rs1800562) and p.H63D (rs179945) [11, 14]. Whereas p.C282Y occurs predomi-
nantly in European whites, p.H63D is cosmopolitan [15]. Among whites of European ancestry
who have hemochromatosis phenotypes, approximately 90% are p.C282Y homozygotes [9,
10]. Approximately 10% of European whites are p.C282Y heterozygotes and 24% are p.H63D
heterozygotes [9, 10, 16]. It has been hypothesized that hemochromatosis heterozygosity, later
defined as p.C282Y heterozygosity, increases iron absorption and thereby decreases risk of ID,
especially in women [17, 18].
To learn more, we evaluated initial screening observations on 62,685 women who partici-
pated in the Hemochromatosis and Iron Overload Screening Study (HEIRS Study), a cross-
sectional, multi-ethnic, primary care-based sample of 101,168 adults ages�25 y enrolled dur-
ing a two-year interval at five Field Centers in the US and Canada [19]. Initial screening obser-
vations included age, self-identified race/ethnicity, measurement of transferrin saturation (TS)
and serum ferritin (SF), HFE p.C282Y and p.H63D genotyping, and self-reported pregnancy.
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We defined ID as combined initial screening TS <10% and SF<33.7 pmol/L (<15 μg/L), con-
sistent with previous studies [1, 2, 20, 21]. We compared the prevalence of ID in women of dif-
ferent race/ethnicity subgrouped by age. We also determined relationships of ID to p.C282Y
and p.H63D, with or without self-reported pregnancy. We discuss our findings in the context
of other reports of the prevalence of and risk factors for ID in women who reside in the US or
Canada.
Materials and methods
Subjects
The National Institutes of Health HEIRS Study (January 2000-January 2006) evaluated the
prevalence, genetic and environmental determinants, and potential clinical, personal, and soci-
etal effects of hemochromatosis and iron overload in a multi-ethnic, primary care-based sam-
ple of 101,168 adults enrolled during a two-year interval (2001–2003) at four Field Centers in
the US (Birmingham, Alabama; Irvine, California; Washington, D.C.; and Portland, Oregon/
Honolulu, Hawaii) and one in Canada (London, Ontario) [19].
This Study was conducted in accordance with the principles of the Declaration of Helsinki.
The local Institutional Review Board of each Field Center approved the Study protocol [5, 9].
The Field Center Institutional Review Boards included: UAB Institutional Review Board for
Human Use (Birmingham, Alabama); UC Irvine Institutional Review Board (Irvine, Califor-
nia); Howard University Institutional Review Board (Washington, D.C.); Kaiser Permanente
Northwest Region IRB (Portland, Oregon); Kaiser Permanente Hawaii Region IRB (Honolulu,
Hawaii); and University of Western Ontario Research Ethics Board for Health Sciences
Research Involving Human Subjects (London, Ontario). Participants,�25 y of age who were
able to give written informed consent, were recruited from a health maintenance organization,
diagnostic blood collection centers, and public and private primary care offices in ambulatory
clinics associated with the Field Centers. Initial screening included TS and SF phenotyping
and HFE genotyping (p.C282Y (rs1800562) and p.H63D (rs179945) alleles) [5, 9].
Race/ethnicity was determined by self-reported answers to two questions: one regarding
Hispanic background; and another offering a non-exclusive choice of five race/ethnicity
groups. Participants who identified themselves as having Hispanic, Latino, or Spanish heritage
were classified as Hispanic, regardless of additional race/ethnicity identification or Field Cen-
ter. Participants who self-identified themselves as non-Hispanic white or Caucasian were clas-
sified as whites. Participants classified as blacks included self-identified African Americans/
non-Hispanic blacks recruited at US Field Centers (especially central Alabama (University of
Alabama at Birmingham) and Washington, D.C. (Howard University)) and self-identified
black, African, Haitian, Jamaican, or Somali participants recruited at the Ontario Field Center
only. Self-identified Asians were so classified. Participants who reported any Hawaiian or
other Pacific Islander heritage were classified as Pacific Islanders. Participants who identified
themselves as American Indian or Alaska Native at US Field Centers (or North American
Indian, Metis, or Inuit at the Ontario Field Center only) were classified as Native Americans
[19, 22]. Participants who reported two or more race/ethnicity groups or unknown race/eth-
nicity were classified as Other.
Self-reported pregnancy data were obtained from an initial screening question with three
possible responses: pregnant; not sure; or not pregnant. For these analyses, we excluded partic-
ipants who answered "not sure."
We excluded participants who reported learning of the HEIRS Study from a participating
family member or who reported on their screening questionnaire that they had been
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previously diagnosed to have hemochromatosis or iron overload [19]. We also excluded partic-
ipants with incomplete data pertinent to the present study.
Laboratory methods
Blood samples were obtained at initial screening for measurement of TS and SF (without
regard for state of fasting) and HFE mutation analysis [22]. The Central Laboratory (located at
Advanced Research and Diagnostic Laboratory at the University of Minnesota, Minneapolis,
MN) performed all screening tests, except TS testing of London Health Sciences Centre partic-
ipants (performed by MDS Laboratory Services, Canada, using an almost identical method).
Measurements included spectrophotometric serum iron and unsaturated iron-binding capac-
ity, turbidometric immunoassay of SF (Roche Diagnostics/Hitachi 911, Indianapolis, IN,
USA), and calculated total iron-binding capacity and TS [19]. Analytical variability was deter-
mined for TS and SF by analysis of routine internal laboratory quality control pools in each
analytical batch. For TS measurements, the batch-to-batch coefficient of variation was 3.0%.
The correlation coefficient of original participant values and blind replicates was 0.98. For SF
measurements, the batch-to-batch coefficient of variation was 4.7%. The correlation coefficient
of original participant values and blind replicates was 0.99 [23].
HFE p.C282Y and p.H63D were detected as reported in detail elsewhere [19, 23]. Specimens
for which initial results were inconclusive were evaluated further using a different method to
resolve uncertainty about genotypes [23].
Definition of iron deficiency
We defined ID as the combination of initial screening TS <10% and initial screening SF <33.7
pmol/L (<15 μg/L), consistent with previous studies [1, 2, 20, 21].
Statistics
We analyzed observations on 62,685 women who underwent initial HEIRS Study screening
for whom these data were complete: race/ethnicity, age, TS, SF, and HFE alleles. We also ana-
lyzed association of self-reported pregnancy (and self-reported non-pregnancy) and HFE
alleles in women ages 25–44 y with ID. Most descriptive data are displayed as enumerations,
percentages, or means ± 1 standard deviation. Percentages were compared using the likelihood
ratio chi-square test or Fisher’s exact test (two-tailed), as appropriate. Mean values were com-
pared using Student t-test (two-tailed) for two groups or F statistic from a linear model for
Table 1. Iron deficiency (ID) in 62,685 women in the HEIRS studya.
Race/ethnicity (n) FeDef, % (n) Mean age, y (± 1 SD)
Hispanic (8,566) 5.14 (440) 43.91 ± 13.03
Black (17,272) 4.31 (744) 48.69 ± 14.48
White (27,079) 1.99 (539) 51.81 ± 14.22
Asian (7,615) 2.10 (160) 50.04 ± 13.50
Pacific Islander (449) 3.12 (14) 51.82 ± 13.96
Native American (441) 5.22 (23) 47.61 ± 13.97
Otherb (1,263) 2.93 (37) 49.84 ± 13.50
aID was defined as combined initial screening transferrin saturation <10% and initial screening serum ferritin
<15 μg/L.
bParticipants who reported two or more race/ethnicity groups or unknown race/ethnicity were classified as Other.
https://doi.org/10.1371/journal.pone.0232125.t001
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more than two groups. We also compared ages of race/ethnicity groups using an analysis of
variance (ANOVA) test. Values of p<0.05 were defined as significant. Analyses were per-
formed with SAS v. 9.0 (SAS Institute, Cary, NC, USA), Excel 20001 (Microsoft Corp., Red-
mond, WA, USA), and GB-Stat1 (v. 10.0, 2003, Dynamic Microsystems, Inc., Silver Spring,
MD, USA).
Results
Iron deficiency in race/ethnicity groups
There were significant differences between proportions of women with ID across race/ethnic-
ity groups (p<0.0001, likelihood ratio chi-square = 334.84 with 6 degrees of freedom) and
mean age by race/ethnicity (p<0.0001, F statistic = 363.37 with 6 numerator degrees of free-
dom and 62,678 denominator degrees of freedom) (Table 1). A comparison of the prevalence
of ID in the first two groups (Hispanic and black) vs. the second two groups (white and Asian)
yielded a Fisher’s exact test value of p <0.0001, ignoring the three smallest groups (Pacific
Islander, Native American, and Other) (Table 1). Comparisons of the mean ages of the same
two respective groups yielded p<0.0001 (ANOVA test). Proportions of Hispanic and black
women with ID were significantly higher than those of white or Asian women. Proportions of
women classified as Pacific Islander, Native American, and Other race/ethnicity with ID were
lower than those of white or Asian women, although the overall numbers of women with
Pacific Islander, Native American, and Other race/ethnicity were low (Table 1).
Iron deficiency by age subgroup
ID was more prevalent in Hispanic, black, white, and Asian women ages 25–54 y than in
women ages�55 y of each respective race/ethnicity (Fig 1). The prevalence of ID in Hispanic
and black women ages 25–54 y was greater than that of white or Asian women ages 25–54 y (p
<0.0001 for both the likelihood ratio test using all race/ethnicity groups, and Fisher’s exact test
using two race/ethnicity groups indicated above). In women ages�55 y, differences in the
prevalence of ID across Hispanic, black, white, and Asian groups were not significant
(p = 0.095 based on likelihood ratio test using all race/ethnicity groups and p = 0.394 based on
Fisher’s exact test using combinations of two race/ethnicity groups) (Fig 1).
Of 14 Pacific Islander women with ID, 12 (85.7%) were ages 25–54 y. Of 23 Native Ameri-
can women with ID, 22 (95.7%) were ages 25–54 y. Of 37 women classified as Other race/eth-
nicity, 36 (97.3%) were ages 25–54 y.
Iron deficiency and HFE p.C282Y and p.H63D
The prevalence of HFE p.C282Y and p.H63D alleles did not differ significantly in women with
or without ID, regardless of race/ethnicity or age subgroup (Table 2). The prevalence of p.
C282Y homozygosity did not differ significantly in women with or without ID, regardless of
race/ethnicity or age subgroup. In comparisons of zero alleles vs. one allele similar to those dis-
played in Table 2, we observed no significant differences (data not shown).
Pregnancy in women with iron deficiency
Proportions of white and Native American women with ID who reported pregnancy were sig-
nificantly greater than proportions of women of the corresponding race/ethnicity groups who
reported no pregnancy (Table 3). The proportion of black women with ID who reported preg-
nancy was significantly lower than the proportion of black women who reported no pregnancy
(Table 3). The proportion of Native American women with ID who reported pregnancy was
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significantly higher than the proportion of Native American women who reported no preg-
nancy, although the number of Native American women who reported pregnancy was rela-
tively low (Table 3).
HFE p.C282Y and p.H63D alleles in iron-deficient women by pregnancy
The prevalence of p.C282Y and p.H63D alleles did not differ significantly in women with ID
with or without pregnancy (Table 4). Comparisons on p.C282Y could not be made in Asian
and Pacific Islander women because p.C282Y was not detected in these race/ethnicity sub-
groups (Table 4).
Effect of field center
We detected no evidence of an effect of HFE genotypes either overall or by Field Center in any
race/ethnicity group. In analyses limited to women who reported pregnancy, in the subsets for
which sample sizes allowed a test of Field Center effect, we detected no significant differences.
Fig 1. Frequency histogram of prevalence of iron deficiency (mean ± 1 standard deviation) in 62,685 women. These data represent women who
participated in the Hemochromatosis and Iron Overload Screening Study.
https://doi.org/10.1371/journal.pone.0232125.g001
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Discussion
This HEIRS substudy of 62,685 women represents the largest cohort of women studied for ID
in the US and Canada. The prevalence of ID in women of all race/ethnicity groups was greatest
in women ages 25–54 y, consistent with observations on women ages 20–49 y in the National
Health and Nutrition Examination Survey (NHANES) 1999–2000 [8] and the lower prevalence
of sufficient SF (�38 μg/L) in Canadian women ages 12–49 y than older women [24]. Among
the present women ages 25–54 y, the prevalence of ID was significantly greater in Hispanic
and black women than white and Asian women. In NHANES 1999–2000 and NHANES 2003–
2010, the prevalence of ID was greater among non-Hispanic black and Mexican-American
women than among non-Hispanic white women [8, 25]. Among US women ages 22–44 y
identified as Mexican Americans, Puerto Ricans, or Cubans, the prevalence of low iron status
was greatest in Mexican Americans [26]. Epidemiologic and clinical studies demonstrate that
risk of ID is greatest in women of reproductive age. The predominant causes of ID in pre-
Table 2. Prevalence of iron deficiency in women byHFE p.C282Y and p.H63D allelesa.
Race Age, y HFE allele 0 alleles, % (n subjects) Any allele, % (n subjects) Value of p (0 vs. any alleles)
Hispanic 25–54 p.C282Y 6.19 (6,528) 8.47 (177) 0.2076
Hispanic 25–54 p.H63D 6.19 (5,473) 6.49 (1,232) 0.6960
Hispanic �55 p.C282Y 1.13 (1,771) 0.00 (61) 1.0000
Hispanic �55 p.H63D 1.22 (1,475) 0.56 (357) 0.3990
Black 25–54 p.C282Y 6.00 (11,486) 7.51 (253) 0.2874
Black 25–54 p.H63D 6.01 (11,091) 6.33 (648) 0.7340
Black �55 p.C282Y 0.65 (5,370) 0.70 (142) 0.6104
Black �55 p.H63D 0.68 (5,176) 0.30 (336) 0.7233
White 25–54 p.C282Y 2.95 (13,666) 2.69 (1,747) 0.5975
White 25–54 p.H63D 2.95 (11,214) 2.83 (4,199) 0.7472
White �55 p.C282Y 0.76 (9,911) 0.76 (1,192) 1.0000
White �55 p.H63D 0.83 (8,173) 0.55 (2,930) 0.1368
Asian 25–54 p.C282Y 3.12 (4,741) 12.50 (8) 0.2252
Asian 25–54 p.H63D 3.08 (4,345) 3.71 (404) 0.4562
Asian �55 p.C282Y 0.38 (2,864) 0.00 (2) 1.0000
Asian �55 p.H63D 0.38 (2,615) 0.40 (251) 1.0000
Pacific Islander 25–54 p.C282Y 4.49 (245) 11.11 (9) 0.3577
Pacific Islander 25–54 p.H63D 5.33 (225) 0.00 (29) 0.3706
Pacific Islander �55 p.C282Y 1.05 (190) 0.00 (5) 1.0000
Pacific Islander �55 p.H63D 1.09 (183) 0.00 (12) 1.0000
Native American 25–54 p.C282Y 7.36 (299) 0.00 (9) 1.0000
Native American 25–54 p.H63D 7.88 (241) 4.48 (67) 0.4303
Native American �55 p.C282Y 0.86 (116) 0.00 (11) 1.0000
Native American �55 p.H63D 0.97 (103) 0.00 (24) 1.0000
Otherb 25–54 p.C282Y 4.39 (775) 2.00 (50) 0.7167
Otherb 25–54 p.H63D 4.46 (672) 3.27 (153) 0.6582
Otherb �55 p.C282Y 0.25 (399) 0.00 (25) 1.0000
Otherb �55 p.H63D 0.28 (362) 0.00 (62) 1.0000
aIron deficiency was defined as the combination of initial screening transferrin saturation <10% and initial screening serum ferritin <33.7 pmol/L (<15 μg/L). Values
of p were obtained using Fisher’s exact test (two-tailed). NA = not available. HFE p.C282Y/p.H63D compound heterozygotes were counted once for each allele. Similar
analyses that excluded p.C282Y/p.H63D compound heterozygotes revealed results consistent with those above (data not shown).
bParticipants who reported two or more race/ethnicity groups or unknown race/ethnicity were classified as Other.
https://doi.org/10.1371/journal.pone.0232125.t002
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menopausal women are iron losses of menstruation, pregnancy, and lactation, although the
risk of ID is also increased in women who have menorrhagia, donate blood, or receive high-
dose aspirin therapy [2]. Women with these conditions may benefit from iron supplementa-
tion [2].
Race/ethnicity differences in onset and duration of menses could explain some of the pres-
ent observations. Menarche occurs at a significantly earlier age in non-Hispanic black girls
than non-Hispanic white [27, 28] and Mexican-American [27] girls. US-born Asian Ameri-
cans had mean age at menarche of 12.1 y, similar to that in whites, and 1.4 y earlier than Asian
women who migrated to the US [29]. Mean duration of bleeding was 5.1 d for African-Ameri-
can and 5.6 d for European-American girls ages 12–14 y [30]. The mean cycle length for Euro-
pean-American and African-American girls ages 12–14 y was 29.3 d and 28.8 d, respectively
[31]. In a community-based, longitudinal Study of Women’s Health Across the Nation, US
Hispanic women ages 42–52 y had more long cycles (�33 d) and fewer short cycles (�22 d)
than US Caucasian, African-American, Chinese, and Japanese women ages 42–52 y [32].
There are differences in numbers of children per mother classified by race/ethnicity.
Among US women ages 40–44 y, Hispanic, black, white, and Asian mothers have had an aver-
age of 2.6, 2.5, 2.3, and 2.2 children, respectively [33]. Fifty percent of Hispanic mothers ages
40–44 y have had three or more children. This proportion is higher than that of blacks (40%),
whites (33%), and Asians (27%) [33]. These observations are consistent with the greater preva-
lence of ID in the present Hispanic and black women ages 25–54 y than white and Asian
women ages 25–54 y.
There are race/ethnicity differences in breastfeeding. In a population-based study, the pro-
portion of Asian-American women who breastfed was slightly higher than that previously
reported in US white women [29]. In the 2004 National Immunization Survey, 50% of non-
Hispanic black children and 72% of US non-Hispanic white children were ever breastfed.
Among those ever breastfed, 43% of non-Hispanic black children and 54% of non-Hispanic
white children continued breastfeeding until at least age 6 months [34]. The duration of breast-
feeding was similar in US-born Asians [29]. Among major US race/ethnicity groups, Asian
and Hispanic women achieve the highest rates of breastfeeding initiation and continuation at
6 months and 12 months. African-American women have the lowest rates [35]. The iron con-
tent of human breast milk is 0.5–1.0 mg/L [36, 37]. The quantity of iron lost by lactation is
0.5–1.0 mg daily [2]. Increasing duration of breast feeding of U.S. children is associated with
increasing risk of decreased iron stores or ID [38, 39], although the iron content of human
Table 3. Self-reported pregnancy in women ages 25–44 y with iron deficiency (ID)a.
Race/ethnicity Pregnant with ID, % (n) Not pregnant with ID, % (n) Value of p
Hispanic 7.82 (563) 6.17 (5,430) 0.1447
Black 3.52 (369) 6.11 (10,109) 0.0438
White 4.41 (862) 2.82 (14,351) 0.0118
Asian 4.97 (181) 3.14 (4,262) 0.1907
Pacific Islander 6.25 (16) 4.44 (225) 0.5381
Native American 25.00 (20) 6.34 (268) 0.0118
Otherb 3.57 (28) 4.17 (744) 1.0000
aID was defined as the combination of initial screening transferrin saturation <10% and initial screening serum
ferritin <33.7 pmol/L (<15 μg/L). Values of p were obtained using Fisher’s exact test (two-tailed). NA = not
available.
bParticipants who reported two or more race/ethnicity groups or unknown race/ethnicity were classified as Other.
https://doi.org/10.1371/journal.pone.0232125.t003
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breast milk is probably not affected by maternal iron stores [40]. Estimating the effect of lacta-
tion on ID risk must also consider the average numbers of children born to mothers of respec-
tive race/ethnicity groups.
In this study, the prevalence of ID in women ages�55 y was lower than that of younger
women and did not differ significantly across race/ethnicity groups. The prevalence of ID in
Framingham residents ages 67–96 y was also low [41]. In NHANES 1988–1994, SF levels
increased in women after menopause. The increase was more rapid and maximum SF levels
were greater for black women than white and Hispanic women of similar ages [7]. In the
HEIRS Study, TS and SF began to increase at a younger age in black than white women, and
the rate of increase of both TS and SF was greater in black than white women [23]. The most
common cause of ID in post-menopausal women is gastrointestinal blood loss [2].
Dietary intake did not account for differences in low iron stores among Mexican-American
and non-Hispanic white women who participated in NHANES 1988–1994 [42]. In NHANES
Table 4. HFE p.C282Y and p.H63D alleles in iron-deficient women by pregnancya.
Race Pregnancy HFE allele 0 alleles, % (n subjects) Any allele, % (n subjects) Value of p
Hispanic Yes p.C282Y 7.79 (552) 9.09 (11) 0.5949
Hispanic Yes p.H63D 8.37 (466) 5.15 (97) 0.4045
Hispanic No p.C282Y 6.13 (5,257) 7.51 (173) 0.4220
Hispanic No p.H63D 6.00 (4,397) 6.87 (1,033) 0.3142
Black Yes p.C282Y 3.31 (362) 14.29 (7) 0.2237
Black Yes p.H63D 3.70 (351) 0.00 (18) 1.0000
Black No p.C282Y 6.08 (9,887) 7.66 (222) 0.3204
Black No p.H63D 6.10 (9,561) 6.39 (548) 0.7830
White Yes p.C282Y 4.90 (735) 1.57 (127) 0.1035
White Yes p.H63D 4.62 (628) 3.85 (234) 0.7119
White No p.C282Y 2.87 (12,456) 2.53 (1,895) 0.4567
White No p.H63D 2.88 (10,205) 2.68 (4,146) 0.5408
Asian Yes p.C282Y 4.97 (181) NA -
Asian Yes p.H63D 5.17 (174) 0.00 (7) 1.0000
Asian No p.C282Y 3.13 (4,254) 12.50 (8) 0.2257
Asian No p.H63D 3.11 (3,889) 3.49 (373) 0.6420
Pacific Islander Yes p.C282Y 6.25 (16) NA -
Pacific Islander Yes p.H63D 7.14 (14) 0.00 (2) 1.0000
Pacific Islander No p.C282Y 4.17 (216) 11.11 (9) 0.3408
Pacific Islander No p.H63D 5.00 (200) 0.00 (25) 0.6072
Native American Yes p.C282Y 26.32 (19) 0.00 (1) 1.0000
Native American Yes p.H63D 27.78 (18) 0.00 (2) 1.0000
Native American No p.C282Y 6.61 (257) 0.00 (11) 1.0000
Native American No p.H63D 6.93 (202) 4.55 (66) 0.7711
Otherb Yes p.C282Y 3.70 (27) 0.00 (1) 1.0000
Otherb Yes p.H63D 3.70 (27) 0.00 (1) 1.0000
Otherb No p.C282Y 4.20 (690) 3.70 (54) 1.0000
Otherb No p.H63D 4.36 (597) 3.40 (147) 0.8178
aIron deficiency was defined as the combination of initial screening transferrin saturation <10% and initial screening serum ferritin <33.7 pmol/L (<15 μg/L). Values
of p were obtained using Fisher’s exact test (two-tailed). NA = not available. HFE p.C282Y/p.H63D compound heterozygotes were counted once for each allele. Similar
analyses that excluded p.C282Y/p.H63D compound heterozygotes revealed results consistent with those above (data not shown).
bParticipants who reported two or more race/ethnicity groups or unknown race/ethnicity were classified as Other.
https://doi.org/10.1371/journal.pone.0232125.t004
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2003–2006 participants, non-Hispanic blacks had lower dietary iron intake than non-Hispanic
whites and Mexican Americans, but supplemental iron intake was unrelated to race/ethnicity
[43].
Helicobacter pylori gastritis increases the risk of ID with or without peptic ulcer and the risk
increases with increasing age [44, 45]. Analyses of NHANES 1988–1991 data revealed that
antibody positivity for H. pylori is associated with a 40% increase in the prevalence of ID, after
adjustment for other pertinent factors [46], although the specificity of antibody testing for
active infection is <80% [47]. Among healthy asymptomatic residents of the Houston metro-
politan area ages 15–80 y, the prevalence of H. pylori infection was twice as great in blacks as
whites by 13C-urea breath testing [48]. The sensitivity and specificity for active infection typi-
cally exceed 95% [47]. The age-adjusted prevalence of antibody positivity for H. pylori was
62% in Mexican Americans, 53% in non-Hispanic blacks, and 26% non-Hispanic whites in
NHANES 1988–1991 [44]. US Hispanics and Native Americans/Alaskan Natives have higher
rates of H. pylori antibody positivity than whites [49, 50]. In HEIRS Study participants without
ID in another report, the prevalence of H. pylori antibody positivity was significantly greater in
Asian/Pacific Islander participants than control subjects [51]. The prevalence of H. pylori anti-
body positivity did not differ significantly between white, black, and Hispanic participants
with or without ID, respectively [51].
The prevalence of celiac disease in the US is 0.71% (95% confidence interval: 0.58–0.86%)
and in US non-Hispanic whites is 1.01% (95% confidence interval: 0.78–1.31%) [52]. Some
persons with celiac disease also have ID [53]. In a HEIRS substudy, the prevalence of celiac dis-
ease was significantly greater in whites than non-whites, and the odds of celiac disease in men
ages�25 y and women ages�50 y participants with SF�12 μg/L was 28-fold higher than that
of controls [54]. Thus, celiac disease is associated with an increased prevalence of ID in
women, especially white women.
It was hypothesized that hemochromatosis heterozygosity, later defined as HFE p.C282Y
heterozygosity, increases iron absorption and thereby decreases risk of iron-deficiency anemia,
especially in women [17, 18], or that p.C282Y became common in Neolithic Europeans as an
adaptation to low dietary iron content [55]. In the present analyses, the prevalence of ID in
female participants in the HEIRS Study with and without p.C282Y did not differ significantly,
regardless of race/ethnicity or age subgroup. In female Welsh blood donors, mean SF levels
and proportions of women with SF <15 μg/L did not differ significantly between those with p.
C282Y heterozygosity and HFE wild-type genotypes [56]. In Australian women, mean SF lev-
els and prevalence of SF<12 μg/L did not differ significantly between those with p.C282Y het-
erozygosity and HFE wild-type genotypes [57]. In a California health appraisal clinic cohort,
the prevalence of ID without anemia was lower among women with p.C282Y heterozygosity,
but the prevalence of iron-deficiency anemia did not differ significantly between men and
women with or without p.C282Y [58]. In female Danish blood donors, logistic regression on
SF <15 μg/L did not reveal a significant association with p.C282Y, after adjustment for other
variables [59]. In a logistic regression on SF<15 μg/L in non-pregnant, non-lactating His-
panic, black, white, and Asian women in the HEIRS Study, there was no significant association
with p.C282Y, after adjustment for other variables [60]. Taken together, these observations
indicate that p.C282Y heterozygosity has no significant association with ID in women.
HFE protein is one of many upstream regulators of hepcidin transcription and consequent
iron absorption [13]. Hepcidin levels and hepcidin/ferritin ratios are similar in adults with
HFE p.C282Y heterozygosity and wild-type genotypes [61]. p.C282Y heterozygotes do not
absorb dietary heme or non-heme iron more efficiently than control subjects [62]. Non-heme
iron absorption in men with p.C282Y heterozygosity, p.C282Y/p.H63D compound heterozy-
gosity, or HFE wild-type genotypes did not differ significantly [63]. In healthy pregnant
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women unselected for HFE genotypes, hepcidin levels are suppressed in the second and third
trimesters due to incompletely defined mechanisms and contribute to increased iron absorp-
tion [64, 65]. In pregnant women with obesity or other inflammatory disorders, hepcidin levels
may be inappropriately high and thus decrease iron absorption [64, 65].
In the present study, the prevalence of p.C282Y and p.H63D alleles did not differ signifi-
cantly in women with ID with or without self-reported pregnancy. Respective comparisons of
the prevalence of p.C282Y in Asian and Pacific Islander women with ID with or without self-
reported pregnancy could not be made because p.C282Y was not observed in these race/eth-
nicity subgroups. In another study, logistic regression on SF <15 μg/L in pregnant or lactating
women revealed a significant inverse association with p.C282Y, after adjustment for other fac-
tors [60]. Thus, it is plausible but unproven that a subtle effect of p.C282Y heterozygosity or
associated non-HFE genetic or acquired modifiers influence iron absorption during pregnancy
or lactation.
In this study, the prevalence of ID in women with or without HFE p.H63D did not differ
significantly, regardless of race/ethnicity or age subgroup. In female blood donors in Wales,
mean SF levels did not differ significantly between p.H63D heterozygotes, p.H63D homozy-
gotes, and donors with HFE wild-type genotypes [56]. In a California health appraisal clinic
cohort, the overall prevalence of ID without anemia was significantly lower in women with p.
H63D heterozygosity and in women ages <50 y with either p.H63D heterozygosity or homo-
zygosity [58]. In female Danish blood donors, logistic regression on SF<15 μg/L revealed a
significant negative association with p.H63D homozygosity but not heterozygosity, after
adjustment for other variables [59].
The prevalence of ID in the present Asian women ages 25–54 y was low. The T allele at tag
rs9366637 (HFE intron 1, C>T) captured 96% of a haplotype that is common in Asians (54%)
but uncommon in Northwestern Europeans (6%) and East Africans (4%) [66]. Iron absorption
in Asian-American women homozygous for rs9366637 (T/T) was significantly greater than
that of Asian-American women without rs9366637 (C/C) or age-matched Caucasian-Ameri-
can women [66]. Thus, positivity for rs9366637 could partly explain the low prevalence of ID
in the present Asian women ages 25–54 y.
Advantages of this study include the availability of observations for race/ethnicity, age, TS,
SF, HFE p.C282Y and p.H63D, and self-reported pregnancy at a single screening encounter in
a large cohort of women who reside in the US and Canada with complete data, although over-
all numbers of Pacific Islander, Native American, and Other participants were small.
A major goal of the present study was to determine the association of ID (defined as com-
bined TS<10% and SF<15 μg/L) with common HFE alleles. Reduction or absence of storage
iron in the bone marrow and hepatocytes is associated with a continuum of laboratory and
clinical abnormalities, only the most severe of which are typically classified as ID (with or with-
out anemia) [2]. We sought to minimize the numbers of women (pregnant and non-pregnant)
classified as having ID who were "false-positives." Accordingly, we used a stringent definition
of ID consistent with general population survey studies [1, 2, 20, 21]. In other studies that eval-
uated the associations of ID with common HFE alleles, ID was defined as SF <12 μg/L [57] or
SF <15 μg/L [56, 59, 60]. We acknowledge that the present definition of ID could result in an
underestimate of the proportion of women with iron depletion or ID, although ancillary labo-
ratory measures including estimates of stainable iron in bone marrow, levels of hemoglobin,
erythrocytes, serum transferrin receptor, and erythrocyte protoporphyrin typically used to
diagnose or classify pre-latent or latent ID [2] were not available as part of HEIRS Study initial
screening tests.
A limitation of using HEIRS Study initial screening data to evaluate women for ID is the
inability to determine causation of ID in individual women. Socio-economic assessments,
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clinical evaluations, management of ID and its underlying causes, and longitudinal follow-up
of participants were beyond the scope of the HEIRS Study. We did not evaluate age of menar-
che, quantify reproductive (menses, pregnancy, lactation) and non-reproductive iron losses, or
perform analyses to detect uncommon HFE or non-HFE iron-related mutations.
Conclusions
ID prevalence was greater in Hispanic and black than white and Asian women ages 25–54 y. p.
C282Y and p.H63D prevalence did not differ significantly in women with or without ID,
regardless of race/ethnicity, age subgroup, or pregnancy. The present results may inform rec-
ommendations by public health officials and epidemiologists concerning screening women
with increased risk of ID, regardless of race/ethnicity.
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